The importance of genetics in an advanced integrative model of autism spectrum disorder

Abstract

Genes have long been considered to cause autism spectrum disorder (ASD). However, data obtained over the last 10 years indicate that the true role of genetics in ASD and the cost-benefit ratio of genetic testing following an ASD diagnosis warrant further investigation. ASD is heterogeneous with high individual complexity, and new findings related to systemic alterations in ASD (in addition to genetics) should be considered when attempting to optimize patient health. However, for some people with ASD and their families, genetic testing can identify genetic mutations or chromosomic alterations. This review mainly considers recent research (the last 5 years) on the role of genetic factors in ASD and the importance of genetic testing in a new Advanced Integrative Model of ASD.

Keywords

Genetic testing / Advanced Integrative Model / mutation

References

[1] Hoang N,Scherer SW.Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders.NPJ Genom Med2018;3:27 PMCID:PMC6145925

[2] Dias CM.Recent advances in understanding the genetic architecture of autism.Annu Rev Genomics Hum Genet2020;21:289-304

[3] Hertz-Picciotto I,Krakowiak P.Understanding environmental contributions to autism: causal concepts and the state of science.Autism Res2018;11:554-86

[4] Niesler B.Emerging evidence for gene mutations driving both brain and gut dysfunction in autism spectrum disorder.Mol Psychiatry2021;26:1442-4 PMCID:PMC8159735

[5] Ghrálaigh F, McCarthy E, Murphy DN, Gallagher L, Lopez LM. Brief report: evaluating the diagnostic yield of commercial gene panels in autism.J Autism Dev Disord2022;

[6] Zurita MF,Sandoval ME.Analysis of gut microbiome, nutrition and immune status in autism spectrum disorder: a case-control study in Ecuador.Gut Microbes2020;11:453-64 PMCID:PMC7524316

[7] Myers SM,Bernier R.Insufficient evidence for “autism-specific” genes.Am J Hum Genet2020;106:587-95 PMCID:PMC7212289

[8] Lisik MZ,Sieroń AL.Anti-neuronal antibodies in patients with fragile X syndrome: is there a role of autoimmunity in its pathogenesis?.Neurodegener Dis2015;15:45-9

[9] Marco BD, Bonaccorso CM, Aloisi E, D'Antoni S, Catania MV. Neuro-inflammatory mechanisms in developmental disorders associated with intellectual disability and autism spectrum disorder: a neuro- immune perspective.CNS Neurol Disord Drug Targets2016;15:448-63

[10] Barnhill K,Moreno HT.Brief report: implementation of a specific carbohydrate diet for a child with autism spectrum disorder and fragile X syndrome.J Autism Dev Disord2020;50:1800-8

[11] Nolan SO,Binder MS.Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse.PLoS One2022;17:e0262916 PMCID:PMC8797197

[12] Napoli E,Wang JY.Allopregnanolone treatment improves plasma metabolomic profile associated with gaba metabolism in fragile X-associated tremor/ataxia syndrome: a pilot study.Mol Neurobiol2019;56:3702-13 PMCID:PMC6401336

[13] Song G,Wong S.Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine.Mol Med2016;22:548-59 PMCID:PMC5082295

[14] Valenti D,De Filippis B,Vacca RA.Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, Autism, Fragile X and Rett syndrome.Neurosci Biobehav Rev2014;46 Pt 2:202-17

[15] Müller M.Disturbed redox homeostasis and oxidative stress: potential players in the developmental regression in Rett syndrome.Neurosci Biobehav Rev2019;98:154-63

[16] Carlsson T,Butwicka A.Association of cumulative early medical factors with autism and autistic symptoms in a population-based twin sample.Transl Psychiatry2022;12:73 PMCID:PMC8863884

[17] Torres EB.Reframing psychiatry for precision medicine.J Pers Med2020;10:144 PMCID:PMC7711577

[18] Volk HE,Chen A.Considering toxic chemicals in the etiology of autism.Pediatrics2022;149:e2021053012

[19] Bougeard C,Schmid R,Buitelaar J.Prevalence of autism spectrum disorder and co-morbidities in children and adolescents: a systematic literature review.Front Psychiatry2021;12:744709 PMCID:PMC8579007

[20] Leader G,Cunningham S.Gastrointestinal symptoms in autism spectrum disorder: a systematic review.Nutrients2022;14:1471

[21] Isaksson J,Aho N,Marschik PB.Nonshared environmental factors in the aetiology of autism and other neurodevelopmental conditions: a monozygotic co-twin control study.Mol Autism2022;13:8 PMCID:PMC8858556

[22] Wei H,Wang T,Zhang K.Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.J Neural Transm2021;128:717-34

[23] David MM,Ozturk A.Comorbid analysis of genes associated with autism spectrum disorders reveals differential evolutionary constraints.PLoS One2016;11:e0157937

[24] Diaz-Beltran L,Varma M.Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes.BMC Genomics2017;18:1-14

[25] Klein L,Eapen V,Lin PI.Exploring polygenic contributors to subgroups of comorbid conditions in autism spectrum disorder.Sci Rep2022;12:3416 PMCID:PMC8888546

[26] Ferreira ML.Rationale of an advanced integrative approach applied to autism spectrum disorder: review, discussion and proposal.J Pers Med2021;11:514 PMCID:PMC8230111

[27] Cawthorpe D.A 16-year cohort analysis of autism spectrum disorder-associated morbidity in a pediatric population.Front Psychiatry2018;9:635 PMCID:PMC6281889

[28] Ozonoff S,Hanzel EP.Onset patterns in autism: variation across informants, methods, and timing.Autism Res2018;11:788-97 PMCID:PMC5992045

[29] Rose S,Rossignol DA,Kahler SG.Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder.Mol Diagn Ther2018;22:571-93 PMCID:PMC6132446

[30] Goncalves MVM,Braatz V.Pediatric acute-onset neuropsychiatric syndrome (PANS) misdiagnosed as autism spectrum disorder.Immunol Lett2018;203:52-3

[31] Shulyakova N,Mills LR.Mitochondrial dysfunction in the pathogenesis of rett syndrome: implications for mitochondria-targeted therapies.Front Cell Neurosci2017;11:58 PMCID:PMC5348512

[32] Kreiman BL.State of the art of genetic testing for patients with autism: a practical guide for clinicians.Semin Pediatr Neurol2020;34:100804

[33] Stafford CF.Impact of genetic and genomic testing on the clinical management of patients with autism spectrum disorder.Genes2022;13:585 PMCID:PMC9030515

[34] Richards C,Groves L,Oliver C.Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.Lancet Psychiatry2015;2:909-16

[35] Shimizu H,Yamamoto N,Ozawa H.Overlap between epilepsy and neurodevelopmental disorders: insights from clinical and genetic studies. In: Czuczwar SJ, editor. Epilepsy. Exon Publications; 2022. pp. 41-54.

[36] Frye RE,Fatemi SH.Neuropathological mechanisms of seizures in autism spectrum disorder.Front Neurosci2016;10:192 PMCID:PMC4861974

[37] Frye RE.Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder.Epilepsy Behav2015;47:147-57

[38] Kuo SS,Fu JM.Developmental variability in autism across 17 000 autistic individuals and 4000 siblings without an autism diagnosis: comparisons by cohort, intellectual disability, genetic etiology, and age at diagnosis.JAMA Pediatr2022;176:915-23 PMCID:PMC9295026

[39] Mpoulimari I.Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach.Psychiatr Genet2022;32:91-104

[40] Doi M,Usui N.Genomic strategies for understanding the pathophysiology of autism spectrum disorder.Front Mol Neurosci2022;15:930941 PMCID:PMC9263364

[41] Casanova MF,Gillberg C.Editorial: comorbidity and autism spectrum disorder.Front Psychiatry2020;11:617395 PMCID:PMC7714785

[42] Autistica. Personal tragedies, public crisis. Available from: https://www.autistica.org.uk/downloads/files/Personal-tragedies-public-crisis-ONLINE.pdf [Last accessed on 27 Dec 2022]

[43] Wills J. Health and service provision for people with autism spectrum disorders: a survey of parents in the United Kingdom. Available from: https://www.thinkingautism.org.uk/wp-content/uploads/Health__Service_Provision_for_People_with_ASD_March2016.pdf [Last accessed on 27 Dec 2022]

[44] Lord C,Havdahl A.The Lancet Commission on the future of care and clinical research in autism.Lancet Comm2021;399:271-334

[45] Qiu S,Li Y.Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses.Transl Psychiatry2022;12:249 PMCID:PMC9200752

[46] Panisi C,Abruzzo PM.Autism spectrum disorder from the womb to adulthood: suggestions for a paradigm shift.J Pers Med 202111:70 PMCID:PMC7912683

[47] MDPI. Special issue “a personalized medicine approach to the diagnosis and management of autism spectrum disorder”. Available from: https://www.mdpi.com/journal/jpm/special_issues/Personalized_Medicine_Approach_ASD [Last accessed on 27 Dec 2022]

[48] MDPI. Special issue “a personalized medicine approach to the diagnosis and management of autism spectrum disorder: 2022”. Available from: https://www.mdpi.com/journal/jpm/special_issues/asd_personalized [Last accessed on 27 Dec 2022]

[49] Whiteley P,Kapoor RR,Sala R.Autoimmune encephalitis and autism spectrum disorder.Front Psychiatry2021;12:775017 PMCID:PMC8718789

[50] Whiteley P,Shattock P.Research, clinical, and sociological aspects of autism.Front Psychiatry2021;12:481546 PMCID:PMC8116543

[51] Chen YJ,Georgiades S.Rethinking autism intervention science: a dynamic perspective.Front Psychiatry2022;13:827406 PMCID:PMC8915252

[52] Erbescu A,Budisteanu M,Neagu M.Re-emerging concepts of immune dysregulation in autism spectrum disorders.Front Psychiatry2022;13:1006612 PMCID:PMC9626859

[53] Jensen AR,Werner BA,Fletcher TS.Modern biomarkers for autism spectrum disorder: future directions.Mol Diagn Ther2022;26:483-95 PMCID:PMC9411091

[54] Iakoucheva LM,Sebat J.Getting to the cores of autism.Cell2019;178:1287-98 PMCID:PMC7039308

[55] Paulsen B,Kedaigle AJ.Autism genes converge on asynchronous development of shared neuron classes.Nature2022;602:268-73 PMCID:PMC8852827

[56] Shen L,Lin J.A combined proteomics and metabolomics profiling to investigate the genetic heterogeneity of autistic children.Mol Neurobiol2022;59:3529-45

[57] Roe K.Autism spectrum disorder initiation by inflammation-facilitated neurotoxin transport.Neurochem Res2022;47:1150-65

[58] Ohashi K,Miyachi T.Comprehensive genetic analysis of non-syndromic autism spectrum disorder in clinical settings.J Autism Dev Disord2021;51:4655-62

[59] Yu KH,Fox K.The phenotypical implications of immune dysregulation in fragile X syndrome.Eur J Neurol2020;27:590-3

[60] Startin CM,Ball G.Health comorbidities and cognitive abilities across the lifespan in Down syndrome.J Neurodev Disord2020;12:4 PMCID:PMC6979347